Femasys

Femasys Quick Ratio

The Quick Ratio (Acid Test) of Femasys (FEMY) as of Oct 18, 2026 is 2.78. In the previous year, Quick Ratio (Acid Test) was 0.49 — a change of 472.22% (higher).

Quick Ratio

2.78

YoY

472.22%

Last updated:

Quick Ratio (Acid Test) of Femasys is 2025 2.78 . Quick Ratio (Acid Test) of Femasys was 2024 0.49 . It decreases by 472.22% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Femasys Stock analysis

What does Femasys do? Femasys Inc., based in Suwanee, Georgia, is a biomedical company operating in the Health Care sector. It develops non-surgical reproductive healthcare solutions, including FemBloc for permanent birth control and FemaSeed for artificial insemination. The company employs 34 full-time staff and went public on 18 June 2021. Its products aim to improve patient care and health economics through office-based treatments, with FemBloc utilizing dual intrauterine delivery and FemaSeed offering single intrauterine directional delivery for infertility treatment. Femasys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Femasys stock

Quick Ratio (Acid Test) of Femasys is 2.78 in 2025.

Quick Ratio (Acid Test) of Femasys changed from 0.49 to 2.78, representing a 472.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Femasys since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Femasys with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Femasys

All Key Metrics — Femasys